Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series

(2020) Achille Aouba et al.   ANNALS OF THE RHEUMATIC DISEASES

A Dynamic Immune Response Shapes COVID-19 Progression

(2020) Eugenia Ziying Ong et al.   Cell Host & Microbe

An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19

(2020) Veronica Bordoni et al.   CLINICAL INFECTIOUS DISEASES

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy

(2020) Giacomo Grasselli et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease

(2020) Emanuele Pontali et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

(2020) Hasan K. Siddiqi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

(2020) Mingfeng Liao et al.   NATURE MEDICINE

COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression

(2020) Andrea Borghesi et al.   Radiologia Medica

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

(2020) Christopher M Petrilli et al.   BMJ-British Medical Journal

Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation

(2020) Marco Cardone et al.   Frontiers in Immunology

Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy

(2020) Andrea Borghesi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab

(2020) Annette Langer-Gould et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Understanding COVID-19: what does viral RNA load really mean?

(2020) Gavin M Joynt et al.   LANCET INFECTIOUS DISEASES

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

(2020) Iris Navarro‐Millán et al.   Arthritis & Rheumatology

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

(2020) Christian Karagiannidis et al.   Lancet Respiratory Medicine

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

(2020) Thibault Fiolet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Anakinra Therapy for Non-cancer Inflammatory Diseases

(2018) Giulio Cavalli et al.   Frontiers in Pharmacology

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

(2016) Torbjörn Kullenberg et al.   RHEUMATOLOGY